1-3 of 3
Jennifer Rocnik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-Leukemic Activity of the TYK2 Selective Inhibitor Ndi-031301 in T-Cell Acute Lymphoblastic Leukemia

Koshi Akahane, MD PhD, Zhaodong Li, PhD, Julia Etchin, PhD, Alla Berezovskaya, Evisa Gjini, PhD, Craig E Masse, PhD, Wenyan Miao, PhD, Jennifer Rocnik, PhD, Rosana Kapeller, MD PhD, Jeremy R Greenwood, PhD, Hong Tiv, Takaomi Sanda, MD PhD, David M Weinstock, MD, A. Thomas Look, MD
Journal: Blood
Blood (2016) 128 (22): 1596.
https://doi.org/10.1182/blood.V128.22.1596.1596
Published: 2016
Journal Articles

PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene

Zhuyan Guo, Anlai Wang, Weidong Zhang, Mikhail Levit, Qiang Gao, Claude Barberis, Michel Tabart, Jingxin Zhang, Dietmar Hoffmann, Dmitri Wiederschain, Jennifer Rocnik, Fangxian Sun, Josh Murtie, Christoph Lengauer, Stefan Gross, Bailin Zhang, Hong Cheng, Vinod Patel, Laurent Schio, Francisco Adrian, Marion Dorsch, Carlos Garcia-Echeverria, Shih-Min A. Huang
Journal: Blood
Blood (2014) 124 (11): 1777–1789.
https://doi.org/10.1182/blood-2014-01-551234
Published: 2014
Includes: Supplemental data
Journal Articles

FLT3-ITD Cooperates with MOZ-TIF2 in Leukemogenesis in a Murine Bone Marrow Transplantation Model.

Winnie F. Tam, PhD, Jennifer Rocnik, Ph.D., Sarah Wojiski, Ph.D., Kenji Deguchi, M.D., Rachel Okabe, B.S., Ben Lee, M.D. Ph.D., D. Gary Gilliland, Ph.D. M.D.
Journal: Blood
Blood (2006) 108 (11): 1427.
https://doi.org/10.1182/blood.V108.11.1427.1427
Published: 2006